Illinois Attorney General Lisa Madigan filed a lawsuit against Chandler, Ariz.-based Insys Therapeutics Thursday claiming the drug company used deceptive marketing practices to sell its popular pain ...

John Kapoor, the former CEO of Insys Therapeutics, agreed to pay New Jersey $5 million to settle allegations for his role in fueling the opioid epidemic, New Jersey Attorney General Gurbir Grewal ...

Insys Therapeutics is having a bad run. The Arizona-based pharmaceutical company’s stock is down 50 percent from its peak in August. In that time, sales have slumped by tens of millions of dollars—and ...

What: News that the nation's largest pharmacy benefit manager is severing ties with a specialty pharmacy that fills prescriptions for it and a competitor sent shares in Insys Therapeutics tumbling by ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. BOSTON (AP) — The founder of an Arizona ...

WASHINGTON (AP) — An opioid manufacturer has agreed to pay $225 million to resolve federal investigations into allegations that it paid kickbacks and used other illegal marketing tactics to sell a ...

The founder of Insys Therapeutics on Thursday became the first head of a major US pharmaceutical to be convicted of bribing doctors to prescribe addictive painkillers blamed for fueling an opioid ...

* Insys Therapeutics Inc - preliminary estimated revenues from Subsys (fentanyl sublingual spray) for Q3 of 2016 will be in range of $54 million to $55 million * Insys Therapeutics Inc- company ...

PHOENIX, July 27, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY) announced that today it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) ...

Insys Therapeutics has been the subject of controversy since the Department of Health and Human Services contacted it in 2013 requesting insight into commercialization efforts tied to Subsys, its fast ...